Cancers are driven by unique genetic alterations, so what if we targeted these alterations to treat the cancer? It seems...
In 2021, Lillian L. Siu, MD, and Elaine R. Mardis, PhD, FAACR, each received a call from AACR Chief...
Bacteria account for over 75% of the Earth’s population. And while we often think of these microbes as something...
It sounds like something out of Frankenstein, but a new study in the AACR journal Cancer Discovery suggests that...
When faced with a cancer diagnosis, patients often find themselves asking, “How long will I live? Which treatments will...
The milieu of cells, proteins, and vasculature that comprise the tumor microenvironment can hinder efforts to treat cancer. This...
“Where is the field of cancer research going?” posed Robert Vonderheide, MD, DPhil, as he welcomed attendees to “AACR...
“Are you ready to have a great meeting?” Robert Vonderheide, MD, DPhil, asked the nearly 11,000 attendees gathered in...
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option...
The plenary program of the AACR Annual Meeting 2023 kicked off Saturday, April 15, with a session titled “Beating...